Prevalence of Culture-Confirmed Tuberculosis Among Patients with Nontuberculous Mycobacterial Disease

被引:4
作者
He, Yu [1 ]
Wang, Jun-Li [2 ]
Zhang, Yan-An [3 ,4 ]
Wang, Mao-Shui [4 ,5 ,6 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning 530021, Peoples R China
[2] Youjiang Med Univ Nationalities, Affiliated Hosp, Dept Lab Med, Baise, Peoples R China
[3] Shandong Univ, Cheeloo Coll Med, Shandong Publ Hlth Clin Ctr, Dept Cardiovasc Surg, Jinan 250013, Peoples R China
[4] Shandong Key Lab Infect Resp Dis, Jinan, Shandong, Peoples R China
[5] Shandong Univ, Shandong Prov Chest Hosp, Cheeloo Coll Med, Dept Lab Med, Jinan 250013, Peoples R China
[6] Shandong Univ, Cheeloo Coll Med, Shandong Publ Hlth Clin Ctr, Dept Lab Med, Jinan 250013, Peoples R China
来源
INFECTION AND DRUG RESISTANCE | 2022年 / 15卷
关键词
prevalence; tuberculosis; culture; nontuberculous mycobacteria; diagnosis; PULMONARY-DISEASE; CHINA; RISK; COINFECTION; INFECTION; COMPLEX;
D O I
10.2147/IDR.S363765
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Currently, the prevalence of nontuberculous mycobacteria (NTM) strains isolated from mycobacterial cultures has been well characterized. However, the data on the prevalence of tuberculosis (TB) in patients with NTM disease remain unclear. Methods: Between January 2012 and August 2020, consecutive patients with positive mycobacterial cultures were included for analysis. The identification of Mycobacteria spp. was performed using the DNA array method or sequencing of 16S rDNA. NTM disease is diagnosed when the same infectious agent is identified in at least two sputum or is identified in sterile samples. Results: A total of 997 strains were isolated from 828 inpatients. Of them, 261 inpatients (31.5%) were diagnosed as NTM disease. The mean age of the 261 patients was 55.7 +/- 15.5 years old and 64.0% (n = 167) of them were male. The prevalence of cultureconfirmed TB patients among patients with NTM disease was estimated as 8.0% (21/261). Conclusion: TB is common in NTM disease and caution should be taken when initiating the treatment of NTM disease.
引用
收藏
页码:3097 / 3101
页数:5
相关论文
共 26 条
  • [1] Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis
    Andrejak, Claire
    Nielsen, Rikke
    Thomsen, Vibeke O.
    Duhaut, Pierre
    Sorensen, Henrik Toft
    Thomsen, Reimar Wernich
    [J]. THORAX, 2013, 68 (03) : 256 - 262
  • [2] Nontuberculous Mycobacteria Infections at a Provincial Reference Hospital, Cambodia
    Bonnet, Maryline
    San, Kim Chamroeun
    Pho, Yati
    Sok, Chandara
    Dousset, Jean-Philippe
    Brant, William
    Hurtado, Northan
    Eam, Khun Kim
    Ardizzoni, Elisa
    Heng, Seiha
    Godreuil, Sylvain
    Yew, Wing-Wai
    Hewison, Cathy
    [J]. EMERGING INFECTIOUS DISEASES, 2017, 23 (07) : 1139 - 1147
  • [3] Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline
    Daley, Charles L.
    Iaccarino, Jonathan M.
    Lange, Christoph
    Cambau, Emmanuelle
    Wallace, Richard J., Jr.
    Andrejak, Claire
    Boettger, Erik C.
    Brozek, Jan
    Griffith, David E.
    Guglielmetti, Lorenzo
    Huitt, Gwen A.
    Knight, Shandra L.
    Leitman, Philip
    Marras, Theodore K.
    Olivier, Kenneth N.
    Santin, Miguel
    Stout, Jason E.
    Tortoli, Enrico
    van Ingen, Jakko
    Wagner, Dirk
    Winthrop, Kevin L.
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (04) : 905 - 913
  • [4] Deng Y, 2015, ERJ OPEN RES, V1, P00015, DOI [10.1183/23120541.00015-2015, DOI 10.1183/23120541.00015-2015]
  • [5] El Amin NM, 2000, SCAND J INFECT DIS, V32, P47, DOI 10.1080/00365540050164218
  • [6] Occurrence of Nontuberculous Mycobacterial Pulmonary Infection in an Endemic Area of Tuberculosis
    Fusco da Costa, Ana Roberta
    Falkinham, Joseph O., III
    Lopes, Maria Luiza
    Barretto, Adriana Rodrigues
    Felicio, Joao Soares
    Messias Sales, Lucia Helena
    da Costa Bahia, Jeann Ricardo
    Conceicao, Emilyn Costa
    Batista Lima, Karla Valeria
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2013, 7 (07):
  • [7] Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT)
    Griffith, David E.
    Eagle, Gina
    Thomson, Rachel
    Aksamit, Timothy R.
    Hasegawa, Naoki
    Morimoto, Kozo
    Addrizzo-Harris, Doreen J.
    O'Donnell, Anne E.
    Marras, Theodore K.
    Flume, Patrick A.
    Loebinger, Michael R.
    Morgan, Lucy
    Codecasa, Luigi R.
    Hill, Adam T.
    Ruoss, Stephen J.
    Yim, Jae-Joon
    Ringshausen, Felix C.
    Field, Stephen K.
    Philley, Julie V.
    Wallace, Richard J., Jr.
    van Ingen, Jakko
    Coulter, Chris
    Nezamis, James
    Winthrop, Kevin L.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 198 (12) : 1559 - 1569
  • [8] Stool culture for diagnosis of nontuberculous mycobacteria pulmonary disease: An indirect evidence
    He, Yu
    Zhang, Yan-An
    Wang, Mao-Shui
    [J]. JOURNAL OF INFECTION, 2021, 83 (05) : 613 - 615
  • [9] Increased risk of pulmonary tuberculosis in patients with previous non-tuberculous mycobacterial disease
    Hsing, S-C.
    Weng, S-F.
    Cheng, K-C.
    Shieh, J-M.
    Chen, C-H.
    Chiang, S-R.
    Wang, J-J.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2013, 17 (07) : 928 - 933
  • [10] Prevalence of nontuberculous mycobacteria in a tertiary hospital in Beijing, China, January 2013 to December 2018
    Huang, Jing-jing
    Li, Ying-xing
    Zhao, Ying
    Yang, Wen-hang
    Xiao, Meng
    Kudinha, Timothy
    Xu, Ying-chun
    [J]. BMC MICROBIOLOGY, 2020, 20 (01)